| Current Price | $383.94 | Mkt Cap | $56.1B |
|---|---|---|---|
| Open | $379.76 | P/E Ratio | 89.43 |
| Prev. Close | $383.94 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $378.69 - $389.45 | Volume | 703,789 |
| 52-Wk Range | $260.42 - $555.77 | Avg. Daily Vol. | 1,076,137 |
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
| Current Price | $383.94 | Mkt Cap | $56.1B |
|---|---|---|---|
| Open | $379.76 | P/E Ratio | 89.43 |
| Prev. Close | $383.94 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $378.69 - $389.45 | Volume | 703,789 |
| 52-Wk Range | $260.42 - $555.77 | Avg. Daily Vol. | 1,076,137 |
The best Bull and Bear pitches based on recency and number of recommendations.
https://www.fool.com/investing/2017/12/05/why-illumina-jumped-98-in-november.aspx
https://www.fool.com/investing/2018/06/22/illumina-might-be-overlooking-its-top-competitor-h.aspx
Read the most recent pitches from players about ILMN.
Recs
TMFjbonefish
(47.66)
Submitted: 5/5/2021 5:05:06 PM :
Start Price:
$375.93
NASDAQ:ILMN Score:
+0.62
After 20 years, finally facing some competition. The good news for Illumina shareholders is that the market is expanding rapidly. The cheaper sequencing becomes, and the more technologies exist, the more use cases become available. The DNA sequencing industry is expected to grow from the current $8.4 billion to $40 billion over the next decade. That leaves room for a lot of winners. With dominant market share and two decades of innovation behind it, don't expect Illumina to stand still. For investors looking to ride the growth in genome sequencing, the largest, strongest horse with the best track record should be a smart addition to a portfolio.
Recs
CBK
(41.27)
Submitted: 4/23/2021 8:55:10 AM :
Start Price:
$410.93
NASDAQ:ILMN Score:
-8.81
Finishing Walter Isaacson's The Code Breaker has made me believe that the next revolution that we are living in is the genomic revolution. Companies like Illumina, Editas, Crispr, Moderna, and Intellia are powering this revolution.
Recs
Hermanator
(23.25)
Submitted: 2/28/2021 6:56:48 PM :
Start Price:
$449.00
NASDAQ:ILMN Score:
-23.96
Young innovative company
Find the members with the highest scoring picks in ILMN.
OSUChad (94.90) Score: +2,313.49
The Score Leader is the player with the highest score across all their picks in ILMN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| OSUChad | 94.90 | 3/15/2007 |
|
1Y | $14.58 | +2,534.24% | +220.74% | +2,313.49 | 0 Comment | |
| dancon7 | 62.20 | 3/16/2007 |
|
5Y | $14.65 | +2,521.65% | +220.35% | +2,301.29 | 0 Comment | |
| fishman888 | < 20 | 3/16/2007 |
|
1Y | $14.65 | +2,521.65% | +220.35% | +2,301.29 | 0 Comment | |
| dancesct | 94.19 | 3/19/2007 |
|
1Y | $14.69 | +2,513.61% | +220.47% | +2,293.15 | 1 Comment | |
| oncmd | 69.63 | 3/26/2007 |
|
5Y | $14.97 | +2,465.59% | +210.99% | +2,254.60 | 0 Comment | |
| 25000THEVA | 43.47 | 3/22/2007 |
|
NS | $15.23 | +2,420.95% | +211.04% | +2,209.91 | 0 Comment | |
| mpaisis | 36.16 | 4/13/2007 |
|
3W | $15.55 | +2,369.86% | +208.85% | +2,161.01 | 1 Comment | |
| redbellini | < 20 | 3/6/2007 |
|
3M | $15.47 | +2,381.84% | +221.24% | +2,160.60 | 0 Comment | |
| NetscribeBiotech | 87.76 | 3/12/2007 |
|
1Y | $15.73 | +2,341.59% | +219.08% | +2,122.51 | 3 Comments | |
| nachlat | < 20 | 4/10/2007 |
|
3Y | $15.81 | +2,328.46% | +208.36% | +2,120.11 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
